Home › Therapeutic areas › Immunology › Ulcerative Colitis
Ulcerative Colitis (4 companies)
Companies with an active program in Ulcerative Colitis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| EVMN | Evommune | DermatologyImmunology+1 | 1 | Phase 2 | 6 |
| SYRE | Spyre Therapeutics | Immunology | 6 | Phase 2 | 12 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | 26 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 2 | Approved | 30 |
No companies match.